APO RESEARCH · REPORT
Bacillus Coagulans
Bacillus Coagulans is a lactic acid-forming bacterial species within the genus Bacillus. The organism was first isolated and described as Bacillus Coagulans in 1915 by B.W. Hammer at the Iowa Agricultural Experiment Station as a cause of an outbreak of coagulation in evaporated milk packed by an Iowa condensary. Separately isolated in 1935 and described as Lactobacillus sporogenes in the fifth edition of Bergey's Manual, it exhibits characteristics typical of both genera Lactobacillus and Bacillus; its taxonomic position between the families Lactobacillaceae and Bacillaceae was often debated. However, in the seventh edition of Berge’s, it was finally transferred to the genus Bacillus. DNA-based technology was used in distinguishing between the two genera of bacteria which are morphologically similar and possess similar physiological and biochemical characteristics.
Product & engineering
Understand the product.
Bacillus Coagulans is a lactic acid-forming bacterial species within the genus Bacillus. The organism was first isolated and described as Bacillus Coagulans in 1915 by B.W. Hammer at the Iowa Agricultural Experiment Station as a cause of an outbreak of coagulation in evaporated milk packed by an Iowa condensary. Separately isolated in 1935 and described as Lactobacillus sporogenes in the fifth edition of Bergey's Manual, it exhibits characteristics typical of both genera Lactobacillus and Bacillus; its taxonomic position between the families Lactobacillaceae and Bacillaceae was often debated. However, in the seventh edition of Berge’s, it was finally transferred to the genus Bacillus. DNA-based technology was used in distinguishing between the two genera of bacteria which are morphologically similar and possess similar physiological and biochemical characteristics.
Selected research
Industry Research
Bacillus Coagulans Industry Research Report 2026
Market perspective
Bacillus Coagulans is a lactic acid-forming bacterial species within the genus Bacillus. The organism was first isolated and described as Bacillus Coagulans in 1915 by B.W. Hammer at the Iowa Agricultural Experiment Station as a cause of an outbreak of coagulation in evaporated milk packed by an Iowa condensary. Separately isolated in 1935 and described as Lactobacillus sporogenes in the fifth edition of Bergey's Manual, it exhibits characteristics typical of both genera Lactobacillus and Bacillus; its taxonomic position between the families Lactobacillaceae and Bacillaceae was often debated. However, in the seventh edition of Berge’s, it was finally transferred to the genus Bacillus. DNA-based technology was used in distinguishing between the two genera of bacteria which are morphologically similar and possess similar physiological and biochemical characteristics.
North America is the largest consumption place, with a consumption market share nearly 38.9% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 26.8%.
Market competition is intense. Kerry, Sabinsa, Mitsubishi, UAS Laboratories, Synbiotech, etc. are the leaders of the industry, with high-end customers
Read the full market overview
Report Scope
This report quantifies the global Bacillus Coagulans market in terms of revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bacillus Coagulans Market by Company
Kerry
Sabinsa
Mitsubishi
UAS Laboratories
Synbiotech
Syngen Biotech
Sanzyme
Microbax
Bacillus Coagulans Segment by Type
Below 100 B
100-200 B
Above 200 B
Bacillus Coagulans Segment by Application
Drugs
Food and Beverage
Supplement Products
Bacillus Coagulans Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bacillus Coagulans market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bacillus Coagulans and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bacillus Coagulans.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Bacillus Coagulans manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Bacillus Coagulans by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Bacillus Coagulans in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Below 100 B
- 100-200 B
- Above 200 B
Applications
- Drugs
- Food and Beverage
- Supplement Products
Companies covered
- Kerry
- Sabinsa
- Mitsubishi
- UAS Laboratories
- Synbiotech
- Syngen Biotech
- Sanzyme
- Microbax
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Bacillus Coagulans Market Size (2021-2032)
- 2.2.2 Global Bacillus Coagulans Sales (2021-2032)
- 2.2.3 Global Bacillus Coagulans Market Average Price (2021-2032)
- 2.3 Bacillus Coagulans by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Below 100 B
- 2.3.3 100-200 B
- 2.3.4 Above 200 B
- 2.4 Bacillus Coagulans by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Drugs
- 2.4.3 Food and Beverage
- 2.4.4 Supplement Products
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Bacillus Coagulans Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Bacillus Coagulans Sales (t) of Manufacturers (2021-2026)
- 3.3 Global Bacillus Coagulans Revenue of Manufacturers (2021-2026)
- 3.4 Global Bacillus Coagulans Average Price by Manufacturers (2021-2026)
- 3.5 Global Bacillus Coagulans Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Bacillus Coagulans, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Bacillus Coagulans, Product Type & Application
- 3.8 Global Manufacturers of Bacillus Coagulans, Established Date
- 3.9 Global Bacillus Coagulans Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Kerry
- 4.1.1 Kerry Company Information
- 4.1.2 Kerry Business Overview
- 4.1.3 Kerry Bacillus Coagulans Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Kerry Bacillus Coagulans Product Portfolio
- 4.1.5 Kerry Recent Developments
- 4.2 Sabinsa
- 4.2.1 Sabinsa Company Information
- 4.2.2 Sabinsa Business Overview
- 4.2.3 Sabinsa Bacillus Coagulans Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sabinsa Bacillus Coagulans Product Portfolio
- 4.2.5 Sabinsa Recent Developments
- 4.3 Mitsubishi
- 4.3.1 Mitsubishi Company Information
- 4.3.2 Mitsubishi Business Overview
- 4.3.3 Mitsubishi Bacillus Coagulans Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Mitsubishi Bacillus Coagulans Product Portfolio
- 4.3.5 Mitsubishi Recent Developments
- 4.4 UAS Laboratories
- 4.4.1 UAS Laboratories Company Information
- 4.4.2 UAS Laboratories Business Overview
- 4.4.3 UAS Laboratories Bacillus Coagulans Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 UAS Laboratories Bacillus Coagulans Product Portfolio
- 4.4.5 UAS Laboratories Recent Developments
- 4.5 Synbiotech
- 4.5.1 Synbiotech Company Information
- 4.5.2 Synbiotech Business Overview
- 4.5.3 Synbiotech Bacillus Coagulans Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Synbiotech Bacillus Coagulans Product Portfolio
- 4.5.5 Synbiotech Recent Developments
- 4.6 Syngen Biotech
- 4.6.1 Syngen Biotech Company Information
- 4.6.2 Syngen Biotech Business Overview
- 4.6.3 Syngen Biotech Bacillus Coagulans Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Syngen Biotech Bacillus Coagulans Product Portfolio
- 4.6.5 Syngen Biotech Recent Developments
- 4.7 Sanzyme
- 4.7.1 Sanzyme Company Information
- 4.7.2 Sanzyme Business Overview
- 4.7.3 Sanzyme Bacillus Coagulans Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Sanzyme Bacillus Coagulans Product Portfolio
- 4.7.5 Sanzyme Recent Developments
- 4.8 Microbax
- 4.8.1 Microbax Company Information
- 4.8.2 Microbax Business Overview
- 4.8.3 Microbax Bacillus Coagulans Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Microbax Bacillus Coagulans Product Portfolio
- 4.8.5 Microbax Recent Developments
5 Global Bacillus Coagulans Market Scenario by Region
- 5.1 Global Bacillus Coagulans Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Bacillus Coagulans Sales by Region: 2021-2032
- 5.2.1 Global Bacillus Coagulans Sales by Region: 2021-2026
- 5.2.2 Global Bacillus Coagulans Sales by Region: 2027-2032
- 5.3 Global Bacillus Coagulans Revenue by Region: 2021-2032
- 5.3.1 Global Bacillus Coagulans Revenue by Region: 2021-2026
- 5.3.2 Global Bacillus Coagulans Revenue by Region: 2027-2032
- 5.4 North America Bacillus Coagulans Market Facts & Figures by Country
- 5.4.1 North America Bacillus Coagulans Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Bacillus Coagulans Sales by Country (2021-2032)
- 5.4.3 North America Bacillus Coagulans Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Bacillus Coagulans Market Facts & Figures by Country
- 5.5.1 Europe Bacillus Coagulans Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Bacillus Coagulans Sales by Country (2021-2032)
- 5.5.3 Europe Bacillus Coagulans Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Bacillus Coagulans Market Facts & Figures by Country
- 5.6.1 Asia Pacific Bacillus Coagulans Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Bacillus Coagulans Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Bacillus Coagulans Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Bacillus Coagulans Market Facts & Figures by Country
- 5.7.1 South America Bacillus Coagulans Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Bacillus Coagulans Sales by Country (2021-2032)
- 5.7.3 South America Bacillus Coagulans Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Bacillus Coagulans Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Bacillus Coagulans Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Bacillus Coagulans Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Bacillus Coagulans Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Bacillus Coagulans Sales by Type (2021-2032)
- 6.1.1 Global Bacillus Coagulans Sales by Type (2021-2032) & (t)
- 6.1.2 Global Bacillus Coagulans Sales Market Share by Type (2021-2032)
- 6.2 Global Bacillus Coagulans Revenue by Type (2021-2032)
- 6.2.1 Global Bacillus Coagulans Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Bacillus Coagulans Revenue Market Share by Type (2021-2032)
- 6.3 Global Bacillus Coagulans Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Bacillus Coagulans Sales by Application (2021-2032)
- 7.1.1 Global Bacillus Coagulans Sales by Application (2021-2032) & (t)
- 7.1.2 Global Bacillus Coagulans Sales Market Share by Application (2021-2032)
- 7.2 Global Bacillus Coagulans Revenue by Application (2021-2032)
- 7.2.1 Global Bacillus Coagulans Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Bacillus Coagulans Revenue Market Share by Application (2021-2032)
- 7.3 Global Bacillus Coagulans Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Bacillus Coagulans Value Chain Analysis
- 8.1.1 Bacillus Coagulans Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Bacillus Coagulans Production Mode & Process
- 8.2 Bacillus Coagulans Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Bacillus Coagulans Distributors
- 8.2.3 Bacillus Coagulans Customers
9 Global Bacillus Coagulans Analyzing Market Dynamics
- 9.1 Bacillus Coagulans Industry Trends
- 9.2 Bacillus Coagulans Industry Drivers
- 9.3 Bacillus Coagulans Industry Opportunities and Challenges
- 9.4 Bacillus Coagulans Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst